Article
Variation in Sp1 binding sites correlates with expression of survivin in breast cancer.
Molecular medicine reports - 1 Sept 2014
Xu Qing, Liu Mei, Xu Ningzhi, Zhu Hongxia
Abstract excerpt
Survivin is the smallest member of the inhibitor of apoptosis (IAP) family and is deregulated in breast cancer, where it is associated with a poor overall prognosis. It is well established that survivin overexpression predominately occurs at the transcriptional level. Numerous transcription factors bind to specific sequences in the promoter regions of genes and are involved in transcriptional regulation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
